Autopsy report · NCT01190306

Safety Study of the VEGA UV-A System to Treat Keratoconus

“The sponsor terminated the study prior to data analysis for financial reasons.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 4 months before it stopped.
• 127 participants enrolled.
• Results were posted on the registry 1 year 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Topcon Medical Systems, Inc.

Sponsor type

Industry

Conditions

Keratoconus

Interventions

The VEGA UV-A Illumination System; Riboflavin

Participants

127

Sites

9

Countries

United States

Trials that died the same way

• Prospective Case-Series of Ligasure Advance Pistol Grip and LigaSure Blunt Tip
  “The Sponsor terminated the study.” (87% match in meaning)
• Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
  “This study was terminated by the Sponsor.” (86% match in meaning)
• Study of RP-6306 With FOLFIRI in Advanced Solid Tumors
  “Sponsor decided to terminate the study” (85% match in meaning)
• Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera
  “The study was terminated by the sponsor” (85% match in meaning)
• Developing Affective HeaLth to Improve Adherence to Health Behaviors in Diabetes (DAHLIA II)
  “The Sponsor chose to terminate this study for commercial reasons.” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.